medtech
- Home
- medtech
Public
Opening a new frontier in treating Parkinson’s disease
- Review
- November 11, 2022
Is this the most hated company on the ASX?
- Review
- August 16, 2019
Latest Articles
HeraMED’s pregnancy monitoring device expands reach to rural GPs and customers via Telstra Health partnership
Making maternity care more accessible to all expectant parents including those in regional and rural Australians, HeraMED (ASX: HMD) has been promoting at-home pregnancy management using its digital monitoring device HeraCARE. Now the Company has levelled up its strategic shift for the device by securing a new Partner Agreement with Telstra Health, expanding its customer
Read MorePublic
MedAdvisor’s PlusOne platform wins Queensland healthcare pilot contract
Covid-19 reimagined the world’s approach to healthcare. While it put excessive strain on healthcare employees, it urged companies and governments to think outside the box and develop a more sustainable system for the post-pandemic world. Of course, that looked different for everyone. For countries like Estonia and the US, it entailed boosting telehealth services. For
Read MorePublic
TALi enters cash flow positivity, renews Genius Learning agreement and eyes M&A
Parenting is no cakewalk. Over 30% of new Aussie parents worry about their child developing an internet addiction. What’s more, they find parenting all the more challenging if their child has complex issues. Melbourne-based medical device company TALi Digital (ASX: TD1) provides parents with virtual games, like Ready, Attention, Go (which won a Red Dot
Read MorePublic
AHI teams up with Unisure to create digital health insurance app to improve policy pricing
Traditionally, underwriting for health insurance involves conducting blood tests and other examinations to understand how much insurers can afford. However, this process tends to be slow and costly, thus needing a better alternative. That’s where digital healthcare company Advanced Health Intelligence (ASX: AHI) comes in. The Company has entered a Letter of Intent (LOI) with
Read MorePublic
Direct marketing of biotags and global expansion mark BlueChiip’s cheery entry into FY24
A blue chip denotes the cream of the crop—the most put-together, high-quality company or share. So one can only imagine that naming your company Bluechiip would entail high expectations. And high pressure. Two years ago, advanced sampling management company Bluechiip (ASX: BCT) announced that it would directly market its Bluechiip-Enabled products to end-users, concentrating especially
Read MorePublic
Rising demand for IVF from LGBTQI+ community driving Monash IVF market share
Despite the rising cost of living and depression in discretionary spending, fertility company Monash IVF (ASX: MVF) has seen no downturn in demand, despite a round of IVF treatment often costing upwards of $10,000 with no guaranteed success. The broader de-stigmatisation of IVF in Australia through open discussion, media publicity and progressive LGBTIQ+ community have
Read MorePublic
